Chairman of U.S. Bishops’ Conference Committee on Pro-Life Activities Applauds Cancellation of FDA Fetal Tissue Contract, Urges Additional HHS Action
September 27, 2018
WASHINGTON— Cardinal Timothy Michael Dolan, Archbishop of New York and Chairman of the U.S. Conference of Catholic Bishops (USCCB) Committee on Pro-Life Activities, issued a statement today applauding initial steps taken by the Secretary of Health and Human Services to terminate a Food and Drug Administration contract to purchase aborted baby parts for research, but urging quick action to cease all funding for research using body parts from aborted babies.
Cardinal Dolan’s full statement follows:
We applaud Secretary Azar and the Administration for cutting off ties to a company whose business is to procure aborted baby parts for research. Not only has this company been referred for criminal investigation by the House and Senate but using federal tax dollars for such purposes is unethical and unacceptable.
While we are grateful for this first step, it remains incumbent on the Administration to act quickly to cease all funding for research involving body parts from aborted babies. The question is not exclusively what is permitted by law, but what is right and just. For the federal government to create a demand for abortion and use these children’s body parts for research is wrong. We look forward to receiving answers to the questions we and other pro-life organizations asked of Secretary Azar in our September 11, 2018 letter regarding the funding and use of fetal tissue from aborted babies. Under a pro-life Administration, there is simply no room for callously using aborted children to further a research goal. This must stop immediately. Our government should only use taxpayer dollars for ethical research.